These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 6813993)

  • 1. "Lupus" anticoagulant and thrombosis--possible role of inhibition of prostacyclin formation.
    Carreras LO; Vermylen JG
    Thromb Haemost; 1982 Aug; 48(1):38-40. PubMed ID: 6813993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thrombotic phenomena and lupus anticoagulant in a series of 112 patients with systemic lupus erythematosus].
    Ordi Ros J; Vilardell Tarrés M; Barquinero Máñez J; Selva O'Callaghan A; Alijotas Reig J; Bosch Gil J
    Rev Clin Esp; 1987 Feb; 180(2):66-70. PubMed ID: 3105004
    [No Abstract]   [Full Text] [Related]  

  • 3. The lupus anticoagulant in systemic lupus erythematosus.
    Rowell NR; Tate GM
    Acta Derm Venereol; 1989; 69(2):111-5. PubMed ID: 2564226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery in patients with circulating lupus anticoagulant.
    Shaulian E; Shoenfeld Y; Berliner S; Shaklai M; Pinkhas J
    Int Surg; 1981; 66(2):157-9. PubMed ID: 6792105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Lupus" anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intrauterine growth retardation and intrauterine death.
    Carreras LO; Vermylen J; Spitz B; Van Assche A
    Br J Obstet Gynaecol; 1981 Sep; 88(9):890-4. PubMed ID: 6791683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Presence of lupus-type anticoagulant, in systemic lupus erythematosus and other clinical entities].
    Raleigh-Rosendo R; Diez-Ewald M; Vizcaíno G; Fereira H; Arteaga-Vizcaíno M; Arreaza M
    Invest Clin; 1990; 31(1):45-55. PubMed ID: 2128614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recurrent abortions and circulating anticoagulant. Relation to lupic disease: 6 cases].
    Mathieu A; Piette JC; Blétry O; Conard J; Wechsler B; Le Bas J; Serdaru M; Godeau P
    Ann Med Interne (Paris); 1984; 135(7):502-6. PubMed ID: 6517421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lupus-type anticoagulants and thromboses].
    Sultan Y
    Ann Med Interne (Paris); 1986; 137(6):475-6. PubMed ID: 3101565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lupus anticoagulant and recurrent transient ischemic attacks].
    Guerrero A; García-Ruiz P; Bañares A; Rubio M; Escribá A; García-Urra D; Varela de Seijas E
    Neurologia; 1989; 4(6):216-8. PubMed ID: 2517779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lupus anticoagulant--its role and significance in the pathogenesis of thrombosis].
    Styczyńska M; Chojnowski K; Matusewicz W; Krykowski E
    Pol Tyg Lek; 1992 Feb 3-10; 47(5-6):151-3. PubMed ID: 1437805
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of lupus anticoagulant with severe valvular heart disease in systemic lupus erythematosus.
    Ford PM; Ford SE; Lillicrap DP
    J Rheumatol; 1988 Apr; 15(4):597-600. PubMed ID: 3135393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The lupus inhibitor].
    Carreras LO; Vermylen J
    Sangre (Barc); 1981; 26(5-A):610-8. PubMed ID: 6798699
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal vein thrombosis in systemic lupus erythematosus: association with the "lupus anticoagulant".
    Asherson RA; Lanham JG; Hull RG; Boey ML; Gharavi AE; Hughes GR
    Clin Exp Rheumatol; 1984; 2(1):75-9. PubMed ID: 6442640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
    Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
    Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clotting defect in SLE.
    Byron MA
    Clin Rheum Dis; 1982 Apr; 8(1):137-51. PubMed ID: 6811189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased monocyte procoagulant activity independent of the lupus anticoagulant in patients with systemic lupus erythematosus.
    de Prost D; Ollivier V; Ternisien C; Chollet-Martin S
    Thromb Haemost; 1990 Oct; 64(2):216-21. PubMed ID: 2125372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.
    Boey ML; Colaco CB; Gharavi AE; Elkon KB; Loizou S; Hughes GR
    Br Med J (Clin Res Ed); 1983 Oct; 287(6398):1021-3. PubMed ID: 6412932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An IgM lupus anticoagulant that neutralizes the enhancing effect of phospholipid on purified endothelial thrombomodulin activity--a mechanism for thrombosis.
    Freyssinet JM; Wiesel ML; Gauchy J; Boneu B; Cazenave JP
    Thromb Haemost; 1986 Jun; 55(3):309-13. PubMed ID: 3018955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Brain stem infarction, systemic lupus erythematosus and circulating lupus anticoagulant].
    Destée A; Devos P; Prin L; Warot M; Warot P
    Rev Neurol (Paris); 1985; 141(3):236-9. PubMed ID: 3923592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombosis associated with antiphospholipid antibodies cannot be explained by effects on endothelial and platelet prostanoid synthesis.
    Hasselaar P; Derksen RH; Blokzijl L; de Groot PG
    Thromb Haemost; 1988 Feb; 59(1):80-5. PubMed ID: 3129812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.